GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroTech Ltd (HKSE:02172) » Definitions » 14-Day RSI

MicroPort NeuroTech (HKSE:02172) 14-Day RSI : 53.16 (As of May. 31, 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroTech 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-31), MicroPort NeuroTech's 14-Day RSI is 53.16.

The industry rank for MicroPort NeuroTech's 14-Day RSI or its related term are showing as below:

HKSE:02172's 14-Day RSI is ranked better than
50.34% of 886 companies
in the Medical Devices & Instruments industry
Industry Median: 45.455 vs HKSE:02172: 53.16

Competitive Comparison of MicroPort NeuroTech's 14-Day RSI

For the Medical Devices subindustry, MicroPort NeuroTech's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort NeuroTech's 14-Day RSI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroTech's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where MicroPort NeuroTech's 14-Day RSI falls into.



MicroPort NeuroTech  (HKSE:02172) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort NeuroTech  (HKSE:02172) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


MicroPort NeuroTech 14-Day RSI Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroTech's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort NeuroTech (HKSE:02172) Business Description

Traded in Other Exchanges
N/A
Address
No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN
MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing innovative solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.
Executives
Hu Yibin
Biolink Biomedical Ltd. 2201 Interest of corporation controlled by you
Blossom Vision Limited 2201 Interest of corporation controlled by you
Lion Fish Limited 2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited 2301 Trustee
Thriving Hope Limited 2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership 2201 Interest of corporation controlled by you
Biolink Limited 2101 Beneficial owner
Microport Scientific Corporation
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroTech (HKSE:02172) Headlines

No Headlines